Anticancer Effects of Combined γ-Tocotrienol and PPARγ-Antagonist Treatment are Associated with a Suppression in Adipogenic Factor Expression. J. Pharm. Nutr. Sci. 2014;4(1):43-56. doi:10.6000/1927-5951.2014.04.01.7